Morphosys AG ADR (MOR) concluded trading on 01/11/24 at a closing price of $8.63, with 3.48 million shares of worth about $30.05 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 14.15% during that period and on Thursday the price saw a loss of about -7.50%. Currently the company’s common shares owned by public are about 150.38M shares, out of which, 149.93M shares are available for trading.
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 12 analysts are covering the MOR stock and their offered price forecasts bring an average price target of $34.25. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $63.00 and could fall to a lowest price of $11.00. The stock’s current price level is 11.21% above of average price target set by the analysts, while a rise to estimated low would result in gain of 21.55% for the stock. However, touching the estimated high of $63.00 would mean a gain of 86.3% for the stock.
Morphosys AG ADR (NASDAQ: MOR) started trading at $9.18, below -$0.15 from concluding price of the previous day. However, the stock later moved at a day high price of 9.20, or with a loss of -7.50%. Stock saw a price change of -8.29% in past 5 days and over the past one month there was a price change of -2.27%. Year-to-date (YTD), MOR shares are showing a performance of -12.83% which increased to 106.46% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $3.65 but also hit the highest price of $10.51 during that period. The average intraday trading volume for Morphosys AG ADR shares is 1.05 million. The stock is currently trading -9.34% below its 20-day simple moving average (SMA20), while that difference is up 8.32% for SMA50 and it goes to 22.20% higher than SMA200.
Morphosys AG ADR (NASDAQ: MOR) currently have 150.38M outstanding shares and institutions hold larger chunk of about 8.01% of that.
The stock has a current market capitalization of $1.30B and its 3Y-monthly beta is at 1.00. PE ratio of stock for trailing 12 months is 15.16, while it has posted earnings per share of $0.57 in the same period. It has Quick Ratio of 2.86. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MOR, volatility over the week remained 5.68% while standing at 5.62% over the month.
Analysts are in expectations that Morphosys AG ADR (MOR) stock would likely to be making an EPS of -$0.73 in the current quarter, while forecast for next quarter EPS is -$0.4 and it is -$1.71 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.73 which is -$0.73 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $2.61 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -76.64% while it is estimated to increase by 18.40% in next year.
Analysts at 12 brokerage firms have issued recommendations for the Morphosys AG ADR (MOR)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.83. Out of those 12 Wall Street analysts, 8 recommended a “Buy” rating, while 3 were in favor recommending the stock as a “Hold” and 1 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Morgan Stanley on October 13, 2023 offering an Overweight rating for the stock and assigned a target price range of between $3.70 and $9.20 to it.
